Area of research
Epidemiology · Genetics
Research interest
Research interests include Cytomegalovirus and herpesvirus research, Herpesvirus Infections and Treatments, Virus-based gene therapy research, and Poxvirus research and outbreaks.
NPP-669, a Novel Broad-Spectrum Antiviral Therapeutic with Excellent Cellular Uptake, Antiviral Potency, Oral Bioavailability, Preclinical Efficacy, and a Promising Safety Margin
A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge
Targeted disruption of pi–pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activity
Molecular Characterization of Mycoplasma pneumoniae Isolates in the United States from 2012 to 2018
Filociclovir Is a Potent<i>In Vitro</i>and<i>In Vivo</i>Inhibitor of Human Adenoviruses
Synthesis and in vitro anticytomegalovirus activity of 5-hydroxyalkylamino-1,3-oxazoles derivatives
Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program
Advances in the Development of Therapeutics for Cytomegalovirus Infections
Genotypic and Phenotypic Diversity of Herpes Simplex Virus 2 within the Infected Neonatal Population
Hospital-acquired viral respiratory infections in neonates hospitalized since birth in a tertiary neonatal intensive care unit
In vitro activity of novel derivatives of 1,3-oxazole-4-carboxylate and 1,3-oxazole-4-carbonitrile against human cytomegalovirus
New therapies for human cytomegalovirus infections
Xenotransplantation panel for the detection of infectious agents in pigs
A standardized approach to the evaluation of antivirals against DNA viruses: Orthopox-, adeno-, and herpesviruses
Synthesis of A-ring quinolones, nine-membered oxolactams and spiroindoles by oxidative transformations of 2,3-indolotriterpenoids
USC-087 protects Syrian hamsters against lethal challenge with human species C adenoviruses
A standardized approach to the evaluation of antivirals against DNA viruses: Polyomaviruses and lymphotropic herpesviruses
Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysis
Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates
Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis
The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses
Dihydropyrimidinones and -thiones with improved activity against human polyomavirus family members
Synthesis and Antiviral Evaluation of Octadecyloxyethyl Benzyl 9-[(2-Phosphonomethoxy)ethyl]guanine (ODE-Bn-PMEG), a Potent Inhibitor of Transient HPV DNA Amplification
Brincidofovir treatment of acyclovir‐resistant disseminated varicella zoster virus infection in an immunocompromised host
Herpes Simplex Viruses and Varicella Zoster Virus
Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance
The development of new therapies for human herpesvirus 6
Differential Properties of Cytomegalovirus pUL97 Kinase Isoforms Affect Viral Replication and Maribavir Susceptibility
Helicase‐Primase as a Target of New Therapies for Herpes Simplex Virus Infections
Human Cytomegalovirus Gene Expression in Long-Term Infected Glioma Stem Cells